Pharmaceutical Executive: Can you discuss FDA’s history with complex plants? Joel Stanley: In 2004, FDA released its first botanical drug guidance to the industry. This was the first time that complex ...
The drug was finally approved in September 2025 through the FDA’s accelerated approval pathway, based on improvement in knee extensor muscle strength, for adults and children with Barth syndrome who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results